22-040
Showing 1 - 25 of 2,865
Colo-rectal Cancer Trial in Worldwide (Arfolitixorin, Leucovorin)
Active, not recruiting
- Colo-rectal Cancer
-
Gilbert, Arizona
- +93 more
Mar 29, 2022
Postmenopausal Osteoporosis Trial in Worldwide (Romozosumab, Teriparatide)
Completed
- Postmenopausal Osteoporosis
-
Gainesville, Georgia
- +49 more
Nov 4, 2022
Head and Neck Squamous Cell Cancer Trial (pembrolizumab, methotrexate, docetaxel)
Completed
- Head and Neck Squamous Cell Cancer
- pembrolizumab
- +3 more
- (no location specified)
Aug 24, 2022
Type 2 Diabetes Trial in Worldwide (Bexagliflozin, Placebo for Bexagliflozin, Glimepiride)
Osteoarthritis, Knee, Osteoarthritis, Hip Trial in Poland, United Kingdom, United States (Fasinumab, Placebo)
Completed
- Osteoarthritis, Knee
- Osteoarthritis, Hip
- Fasinumab
- Placebo
-
Glendale, Arizona
- +46 more
Dec 2, 2021
Type 2 Diabetes Trial in Worldwide (efpeglenatide (SAR439977), )
Completed
- Type 2 Diabetes Mellitus
- efpeglenatide (SAR439977)
- placebo
-
Birmingham, Alabama
- +53 more
Jan 11, 2022
Ulcerative Colitis, Crohn's Disease Trial in Worldwide (UTTR1147A)
Completed
- Ulcerative Colitis
- Crohn's Disease
-
Greenville, North Carolina
- +56 more
Jul 26, 2022
Chart Review of Repatha® in Subjects With Hyperlipidaemia
Completed
- Hypercholesterolaemia
-
Feldkirch, Austria
- +183 more
Jul 15, 2022
Low Back Pain Trial in Worldwide (Matching Placebo, Low Dose GRT6005, Medium Dose GRT6005)
Completed
- Low Back Pain
- Matching Placebo
- +4 more
-
Senftenberg, Austria
- +78 more
Jul 13, 2021
Colitis, Ulcerative, Obesity Trial in La Jolla (Phentermine-Topiramate, Placebo)
Recruiting
- Colitis, Ulcerative
- Obesity
- Phentermine-Topiramate
- Placebo
-
La Jolla, CaliforniaUniversity of California San Diego
Jun 9, 2022
Dyslipidemia Trial in Worldwide (Evolocumab)
Completed
- Dyslipidemia
- Evolocumab
-
Birmingham, Alabama
- +197 more
Apr 4, 2022
Severe Hypertriglyceridemia Trial in Worldwide (Olezarsen, Placebo)
Recruiting
- Severe Hypertriglyceridemia
- Olezarsen
- Placebo
-
Chula Vista, California
- +109 more
Jan 23, 2023
Post-Menopausal Osteoporosis Trial in Poland, United Kingdom, United States (romosozumab HCP administration with PFS,
Completed
- Post-Menopausal Osteoporosis
- romosozumab HCP administration with PFS
- romosozumab self-administration with AI/Pen
-
Birmingham, Alabama
- +45 more
Nov 5, 2020
Primary Immune Regulatory Disorder, Autoimmune Lymphoproliferative, Immune System Diseases Trial in United States (Emapalumab,
Recruiting
- Primary Immune Regulatory Disorder
- +2 more
- Emapalumab
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Mar 15, 2023
Ultrasonography in First Febrile Urinary Tract Infection
Recruiting
- Urinary Tract Infections
-
Trieste, ItalyIRCCS materno infantile Burlo Garofolo
Apr 13, 2023
Osteoarthritis of the Knee or Hip Trial in Worldwide (Fasinumab, Placebo)
Completed
- Osteoarthritis of the Knee or Hip
- Fasinumab
- Placebo
-
Birmingham, Alabama
- +149 more
Nov 30, 2021
Diabetic Nephropathies Trial in Worldwide (BI 690517, Eplerenone, Placebo)
Completed
- Diabetic Nephropathies
- BI 690517
- +2 more
-
Gentofte, Denmark
- +39 more
Sep 16, 2020
Periodontitis, Diabetes, Type 2 Trial in Istanbul (Non-Surgical Periodontal Treatment)
Completed
- Periodontitis
- Diabetes Mellitus, Type 2
- Non-Surgical Periodontal Treatment
-
Istanbul, TurkeyMarmara University
Nov 11, 2023
Squamous Cell Carcinoma of the Oropharynx Trial in Paris (Tumor Biopsy)
Not yet recruiting
- Squamous Cell Carcinoma of the Oropharynx
- Tumor Biopsy
-
Paris, France
- +2 more
Sep 25, 2023
Peptide (CGRP) as Biomarker of Migraine
Recruiting
- Migraine
- Nociceptive Blink Reflex
-
Greifswald, GermanyUniversity Medicine Greifswald
Mar 3, 2023
Type 2 Diabetes Trial in Worldwide (Sotagliflozin (SAR439954), Placebo, Metformin)
Completed
- Type 2 Diabetes Mellitus
- Sotagliflozin (SAR439954)
- +3 more
-
Litchfield Park, Arizona
- +75 more
Apr 16, 2021